首页 | 本学科首页   官方微博 | 高级检索  
     


Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer
Authors:Ji-Won Kim  Debora K. Kim  Ahrum Min  Kyung-Hun Lee  Hyun-Jin Nam  Jee Hyun Kim  Jin-Soo Kim  Tae-Yong Kim  Seock-Ah Im  In Ae Park
Affiliation:1. Department of Internal Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro-173-beon-gil, Seongnam, 463-707, Korea
2. Seoul International School, 15 Seongnam-daero-1518-beon-gil, Seongnam, 461-830, Korea
3. Cancer Research Institute, Seoul National University, 103 Daehak-ro, Jongno-gu, Seoul, 110-799, Korea
4. Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Korea
5. Department of Internal Medicine, SMG-SNU Boramae Medical Center, 20 Boramae-ro-5-gil, Seoul, 156-707, Korea
6. Department of Pathology, Seoul National University Hospital, 101 Daehak-ro, Seoul, 110-744, Korea
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号